Avid Bioservices, Inc.(NasdaqCM:CDMO) dropped from S&P 600 Health Care (Sector)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.675 USD | -0.97% | +14.81% | +34.77% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.77% | 556M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.42% | 24.52B | |
-14.35% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices, Inc.(NasdaqCM: CDMO) dropped from S&P 600 Health Care